Form 8-K - Current report:
SEC Accession No. 0001104659-21-053479
Filing Date
2021-04-22
Accepted
2021-04-22 09:33:53
Documents
7
Period of Report
2021-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113759d1_8k.htm 8-K 27783
2 EXHIBIT 1.1 tm2113759d1_ex1-1.htm EX-1.1 221616
3 EXHIBIT 5.1 tm2113759d1_ex5-1.htm EX-5.1 8532
4 EXHIBIT 99.1 tm2113759d1_ex99-1.htm EX-99.1 12244
5 GRAPHIC image_002.jpg GRAPHIC 2492
6 GRAPHIC image_003.jpg GRAPHIC 2492
7 GRAPHIC image_001.jpg GRAPHIC 67481
  Complete submission text file 0001104659-21-053479.txt   371713
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21843484
SIC: 2834 Pharmaceutical Preparations